| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Wacker Chemie AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €79.78 |
| 52 Week High | €125.45 |
| 52 Week Low | €76.84 |
| Beta | 1.24 |
| 11 Month Change | -13.39% |
| 3 Month Change | -3.90% |
| 1 Year Change | -32.35% |
| 33 Year Change | -51.48% |
| 5 Year Change | 14.56% |
| Change since IPO | -34.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NR4 | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -3.8% | 0.5% | -1.3% |
| 1Y | -32.3% | -13.8% | 8.9% |
Return vs Industry: 0NR4 underperformed the UK Chemicals industry which returned -13.8% over the past year.
Return vs Market: 0NR4 underperformed the UK Market which returned 8.9% over the past year.
Price Volatility
| 0NR4 volatility | |
|---|---|
| 0NR4 Average Weekly Movement | 4.8% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NR4 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0NR4's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 16,555 | Christian Hartel | www.wacker.com |
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica.
Wacker Chemie AG Fundamentals Summary
| 0NR4 fundamental statistics | |
|---|---|
| Market cap | €3.98b |
| Earnings (TTM) | €124.30m |
| Revenue (TTM) | €5.77b |
32.0x
P/E Ratio0.7x
P/S RatioIs 0NR4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NR4 income statement (TTM) | |
|---|---|
| Revenue | €5.77b |
| Cost of Revenue | €4.89b |
| Gross Profit | €878.20m |
| Other Expenses | €753.90m |
| Earnings | €124.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 12, 2025
| Earnings per share (EPS) | 2.50 |
| Gross Margin | 15.22% |
| Net Profit Margin | 2.15% |
| Debt/Equity Ratio | 39.1% |
How did 0NR4 perform over the long term?
See historical performance and comparison